Andrew Yan - ATAI Life Independent Director
| ATAI Stock | USD 1.87 0.10 5.08% |
Director
Mr. Andrew Y. Yan is Independent Director of ATA Inc. He is the founding managing partner of SAIF Partners IV, III and SB Asia Investment Fund II L.P., and president and executive managing director of Softbank Asia Infrastructure Fund. Before joining Softbank Asia Infrastructure Fund in 2001, Mr. Yan was a managing director and the head of the Hong Kong office of Emerging Markets Partnership from 1994 to 2001. From 1989 to 1994, he worked in the World Bank, the Hudson Institute and US Sprint Co. as an economist, research fellow and director for Asia, respectively, in Washington, DC. From 1982 to 1984, he was the chief engineer at the Jianghuai Airplane Corporationration Mr. Yan was a recipient of Chinas National Thousand Talents Program in 2012 and a member of its Selection Committee. He is a founding director of China Venture and Private Equity Association and a director of Peking University Endowment Investment Committee. He was also selected as one of the Fifty Finest Private Equity Investors in the World by the Private Equity International in 2007 No. 1 VCist of the Year by Forbes in 2008 and 2009. He was named the VC Professional of the Year by Asia VC Journal in 2009. He is currently an independent nonexecutive director of China Petroleum Chemical Corporationrationration, Mengniu Dairy Company Limited, China Resources Land Limited and Fosun International Limited and a nonexecutive director of Guodian Technology Environment Group Corporation Limited, Digital China Holdings Limited, MOBI Development Co., Ltd., eSun Holdings Limited and China Huiyuan Juice Group Limited
| Age | 59 |
| Address | Wallstrasse 16, Berlin, Germany, 10179 |
| Phone | 49 89 2153 9035 |
| Web | https://www.atai.life |
ATAI Life Management Efficiency
The company has return on total asset (ROA) of (0.2552) % which means that it has lost $0.2552 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1721) %, meaning that it created substantial loss on money invested by shareholders. ATAI Life's management efficiency ratios could be used to measure how well ATAI Life manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.14. The current Return On Capital Employed is estimated to decrease to -0.48. As of now, ATAI Life's Total Current Assets are increasing as compared to previous years. The ATAI Life's current Debt To Assets is estimated to increase to 0.06, while Total Assets are projected to decrease to under 261.1 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Jay Lobell | Fortress Biotech | 51 | |
| Douglas Morris | Bio Path Holdings | 68 | |
| Robin Smith | Seelos Therapeutics | 53 | |
| David Barrett | Fortress Biotech | 39 | |
| Jimmie Harvey | Fortress Biotech | 62 | |
| Michael Esq | Fortress Biotech | 58 | |
| Paul Aubert | Bio Path Holdings | N/A | |
| Amy Sing | Bio Path Holdings | 57 | |
| Malcolm Hoenlein | Fortress Biotech | 73 | |
| Michael Garrison | Bio Path Holdings | 46 | |
| Richard Pascoe | Seelos Therapeutics | 53 | |
| Mark Colonnese | Bio Path Holdings | 61 | |
| Heath Cleaver | Bio Path Holdings | 42 | |
| Brian Lian | Seelos Therapeutics | 52 | |
| Daniel OConnor | Seelos Therapeutics | N/A | |
Management Performance
| Return On Equity | -0.17 | ||||
| Return On Asset | -0.26 |
ATAI Life Sciences Leadership Team
Elected by the shareholders, the ATAI Life's board of directors comprises two types of representatives: ATAI Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ATAI. The board's role is to monitor ATAI Life's management team and ensure that shareholders' interests are well served. ATAI Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ATAI Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Glenn Short, Senior Development | ||
| Frank Stegert, Vice Management | ||
| Andrew Yan, Independent Director | ||
| ChengYaw Sun, CEO, Director | ||
| Jun Zhang, President Director | ||
| Christian Angermayer, Founder Board | ||
| Alex Tong, VP of Bus. Devel. and Investor Relations | ||
| Florian Brand, Cofounder CEO | ||
| Anne Johnson, Chief Officer | ||
| Shuqiu Zhao, VP | ||
| Sahil MD, Chief Officer | ||
| Kevin MD, Senior Development | ||
| Benson Tsang, Independent Consultant | ||
| Aaqil Anwar, Mang Relations | ||
| Lin Wang, Co-Founder, Consultant and Director | ||
| Hope Ni, Independent Director | ||
| Xiaofeng Ma, Co-Founder, Chairman, CEO and Chairman of Nominations Committee | ||
| Yiu Tsui, Independent Director | ||
| Rolando MD, Chief Officer | ||
| Stephen Bardin, Advisor | ||
| Ryan Barrett, General VP | ||
| Michael Raven, Senior Operations | ||
| Madison Crawford, Sr Accounting | ||
| Jack Huang, President Director | ||
| Jianmin Ding, Sr. VP of Marketing and Bus. Devel. | ||
| Amy Tung, VP |
ATAI Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ATAI Life a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.17 | ||||
| Return On Asset | -0.26 | ||||
| Current Valuation | 170.71 M | ||||
| Shares Outstanding | 167.41 M | ||||
| Shares Owned By Insiders | 9.90 % | ||||
| Shares Owned By Institutions | 28.03 % | ||||
| Number Of Shares Shorted | 5.55 M | ||||
| Price To Earning | 0.30 X | ||||
| Price To Book | 1.57 X | ||||
| Price To Sales | 1,216 X |
Pair Trading with ATAI Life
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ATAI Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATAI Life will appreciate offsetting losses from the drop in the long position's value.Moving against ATAI Stock
| 0.51 | PFE | Pfizer Inc Earnings Call This Week | PairCorr |
| 0.51 | GILD | Gilead Sciences Earnings Call Today | PairCorr |
The ability to find closely correlated positions to ATAI Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ATAI Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ATAI Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ATAI Life Sciences to buy it.
The correlation of ATAI Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ATAI Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ATAI Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ATAI Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ATAI Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the ATAI Life Sciences information on this page should be used as a complementary analysis to other ATAI Life's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for ATAI Stock analysis
When running ATAI Life's price analysis, check to measure ATAI Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATAI Life is operating at the current time. Most of ATAI Life's value examination focuses on studying past and present price action to predict the probability of ATAI Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATAI Life's price. Additionally, you may evaluate how the addition of ATAI Life to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
Is ATAI Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATAI Life. If investors know ATAI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATAI Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.97) | Earnings Share (0.25) | Revenue Per Share 0.002 | Quarterly Revenue Growth (0.53) | Return On Assets (0.26) |
The market value of ATAI Life Sciences is measured differently than its book value, which is the value of ATAI that is recorded on the company's balance sheet. Investors also form their own opinion of ATAI Life's value that differs from its market value or its book value, called intrinsic value, which is ATAI Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATAI Life's market value can be influenced by many factors that don't directly affect ATAI Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ATAI Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if ATAI Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATAI Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.